Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Lower Limb Spasticity in Japanese Subjects.

Masakado, Yoshihisa; Kagaya, Hitoshi; Kondo, Kunitsugu; Otaka, Yohei; Dekundy, Andrzej; Hanschmann, Angelika; Geister, Thorin L; Kaji, Ryuji

Masakado, Yoshihisa; Kagaya, Hitoshi; Kondo, Kunitsugu; Otaka, Yohei; Dekundy, Andrzej; Hanschmann, Angelika; Geister, Thorin L; Kaji, Ryuji.

Afiliação

Masakado Y; Department of Rehabilitation Medicine, Tokai University School of Medicine, Kanagawa, Japan.
Kagaya H; Department of Rehabilitation Medicine I, School of Medicine, Fujita Health University, Toyoake, Japan.
Kondo K; Department of Rehabilitation Medicine, Tokyo Bay Rehabilitation Hospital, Chiba, Japan.
Otaka Y; Department of Rehabilitation Medicine I, School of Medicine, Fujita Health University, Toyoake, Japan.
Dekundy A; Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany.
Hanschmann A; Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany.
Geister TL; Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany.
Kaji R; Department of Clinical Neuroscience, Tokushima University, Tokushima, Japan.

Front Neurol ; 13: 832937, 2022.

Article em En | MEDLINE | ID: mdl-35370917

Palavras-chave

Japan; botulinum neurotoxin type A; incobotulinumtoxinA; lower limb; spasticity; treatment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Front Neurol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google